missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human FGF acidic/FGF1 (aa 16-155) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 232-FA-025
Additional Details : Weight : 0.00970kg
Description
The Recombinant Human FGF acidic (aa 16-155) Protein is derived from E. coli. The Recombinant Human FGF acidic (aa 16-155) Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 and EDTA with BSA as a carrier protein. | |
| 15.5 kDa | |
| 25μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 3 months, ≤ -20°C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 2246 | |
| FGF acidic aa 16-155 | |
| E. coli-derived human FGF acidic/FGF1 protein Phe16-Asp155, with an N-terminal Met | |
| AFGF, alpha, alpha-ECGF, beta-ECGF, ECGF, ECGFB, ECGF-betaAcidic fibroblast growth factor, endothelial cell growth factor, beta, FGF acidic, FGF-1, FGFABeta-endothelial cell growth factor, FGF-alpha, fibroblast growth factor 1 (acidic), GLIO703, HBGF1, HBGF-1, heparin-binding growth factor 1 | |
| Recombinant |